Figure 5 | British Journal of Cancer

Figure 5

From: Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment

Figure 5

MRI approach to assessing vascular-targeting effect in vivo. The MRI of control 13762 MAT B III rat tumour (white circle) and PDT-treated tumour (0.8 mg kg−1 ADPM06+150 J cm−2 light) (dashed white circle) at ∼3, 24, and 48 h post-treatment with a Gd-DTPA injection, illustrating the change in tumour perfusion.

Back to article page